65 related articles for article (PubMed ID: 2418788)
1. [Current status of combination chemotherapy].
Ogawa M
Gan To Kagaku Ryoho; 1986 Feb; 13(2):171-9. PubMed ID: 2418788
[TBL] [Abstract][Full Text] [Related]
2. Randomized trial comparing bleomycin/etoposide/cisplatin with alternating cisplatin/cyclophosphamide/doxorubicin and vinblastine/bleomycin regimens of chemotherapy for patients with intermediate- and poor-risk metastatic nonseminomatous germ cell tumors: Genito-Urinary Group of the French Federation of Cancer Centers Trial T93MP.
Culine S; Kramar A; Théodore C; Geoffrois L; Chevreau C; Biron P; Nguyen BB; Héron JF; Kerbrat P; Caty A; Delva R; Fargeot P; Fizazi K; Bouzy J; Droz JP;
J Clin Oncol; 2008 Jan; 26(3):421-7. PubMed ID: 18202419
[TBL] [Abstract][Full Text] [Related]
3. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
Thigpen T; Vance R; Puneky L; Khansur T
Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of chemotherapy in urologic cancer].
Miki T; Kuroda M; Kotake T
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1349-57. PubMed ID: 2471457
[TBL] [Abstract][Full Text] [Related]
6. [New salvage chemotherapy (cisplatin, adriamycin, bleomycin, methotrexate, etoposide) for advanced nonseminomatous testicular cancer: experience in three cases].
Ikeda I; Shuin T; Yao M; Kubota Y; Hosaka M
Hinyokika Kiyo; 1993 Mar; 39(3):237-42. PubMed ID: 7685142
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].
Nishio M; Kagami Y; Narimatsu N; Asano K; Sanbe S; Somekawa Y
Gan To Kagaku Ryoho; 1989 Sep; 16(9):3111-8. PubMed ID: 2476971
[TBL] [Abstract][Full Text] [Related]
8. Potential advances in combination chemotherapy for advanced testicular cancer.
Kaye SB; Stoter G; Sleijfer D; Jones W; Ten Bokkel Huinink W; Splinter T; Van Oosterom A; Harris A; Boven E; De Pauw M
Prog Clin Biol Res; 1988; 269():461-9. PubMed ID: 2455913
[TBL] [Abstract][Full Text] [Related]
9. [Combination chemotherapy--present status and problems].
Furue H
Gan To Kagaku Ryoho; 1999 Apr; 26(5):589-96. PubMed ID: 10234287
[TBL] [Abstract][Full Text] [Related]
10. ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to date.
Harper P
Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-23-S15-25. PubMed ID: 9346217
[TBL] [Abstract][Full Text] [Related]
11. [Effective combined injection method of fluoropyrimidine and platinum--application for advanced esophageal cancer].
Ide H; Eguchi R; Nakamura T; Hayashi K
Gan To Kagaku Ryoho; 1996 Nov; 23(13):1757-62. PubMed ID: 8937485
[TBL] [Abstract][Full Text] [Related]
12. [Improvement of survival of testicular cancer patients through chemotherapy].
Miyanaga N; Hayashi H; Akaza H; Koiso K
Gan To Kagaku Ryoho; 1995 May; 22(6):739-45. PubMed ID: 7538744
[TBL] [Abstract][Full Text] [Related]
13. Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study.
Long HJ; Monk BJ; Huang HQ; Grendys EC; McMeekin DS; Sorosky J; Miller DS; Eaton LA; Fiorica JV;
Gynecol Oncol; 2006 Mar; 100(3):537-43. PubMed ID: 16216315
[TBL] [Abstract][Full Text] [Related]
14. [Preoperative chemotherapy of testicular cancer and Wilm's tumor].
Kawai T
Gan To Kagaku Ryoho; 1985 May; 12(5):1025-30. PubMed ID: 2581512
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent carcinoma of the uterine cervix and vagina.
Long HJ; Cross WG; Wieand HS; Webb MJ; Mailliard JA; Kugler JW; Tschetter LK; Kardinal CG; Ebbert LP; Rayson S
Gynecol Oncol; 1995 May; 57(2):235-9. PubMed ID: 7729741
[TBL] [Abstract][Full Text] [Related]
16. [Ambulatory use of cisplatin. Preliminary considerations].
de Oliveira Filho JA; da Cunha FM
Rev Paul Med; 1983; 101(5):199-202. PubMed ID: 6200911
[No Abstract] [Full Text] [Related]
17. [A randomized study comparing cisplatin alone or combined in the palliative treatment of carcinoma of the head and neck. Analysis of a series of 209 patients].
Chauvergne J; Cappelaere P; Fargeot P; Meeus L; Gary-Bobo J; Klein T; Clavel B; David M
Bull Cancer; 1988; 75(1):9-22. PubMed ID: 2451954
[TBL] [Abstract][Full Text] [Related]
18. [Recent controversy in treatment for advanced bladder cancer].
Ozono S; Hirao Y
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1696-700. PubMed ID: 9757194
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy and radiotherapy for urological cancer].
Miyanaga N; Tsukamoto S; Hattori K; Kawai K; Shimazui T; Uchida K; Akaza H
Gan To Kagaku Ryoho; 2002 May; 29(5):709-16. PubMed ID: 12040674
[TBL] [Abstract][Full Text] [Related]
20. [Results of combination chemotherapy in advanced urothelial cancer].
Komatsubara S; Watanabe M; Kitamura Y; Sakata Y
Hinyokika Kiyo; 1988 Oct; 34(10):1697-702. PubMed ID: 3245518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
